BRCA1 and non-small cell lung carcinoma: The value of the BRCA1 as a predictive marker for the treatment customisation in NSCLC has, also, been investigated in several retrospective studies (Taron et al, 2004; Boukovinas et al, 2008) and in one prospective trial (Boukovinas et al, 2008; Rosell et al, 2009).